In breast cancer, the landscape of NER-related genetic mutations varies by races; increased risks of developing breast cancer in women are found to be correlated with different ERCC1, XPC, or XPD polymorphisms in postmenopausal Chinese and American women [54–56]. Here, ERCC2 is linked to breast carcinoma.